---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000049"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-05-20T23:59:59+00:00"
generated_at: "2026-05-20T23:28:34.779201+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ANI Pharmaceuticals presents at conference; no new material financial disclosure

## Summary
- CEO Nikhil Lalwani presenting at H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025.
- Investor presentation furnished as Exhibit 99.1; no specific financial results or guidance included in the 8-K.
- Presentation likely covers corporate overview and recent developments, but details not provided in filing text.

## SEC filing metadata
- accession: 0001023024-25-000049
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-05-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000049/0001023024-25-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000049/ani-20250520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000049
- JSON: https://secwatch.observer/filing/0001023024-25-000049.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.